Page last updated: 2024-08-25

eletriptan and sertraline

eletriptan has been researched along with sertraline in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Frith, AA; Hackshaw, A; MacGregor, EA	1

Reviews

1 review(s) available for eletriptan and sertraline

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for eletriptan and sertraline

Article	Year
Efficacy, safety, and tolerability of sertraline on depressive symptoms in women with comorbid migraine: an open-label study. Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:3 Topics: Adult; Depression; Female; Humans; Middle Aged; Migraine Disorders; Pyrrolidines; Quality of Life; Selective Serotonin Reuptake Inhibitors; Self Report; Serotonin Receptor Agonists; Sertraline; Tryptamines	2011

Article

Year

Efficacy, safety, and tolerability of sertraline on depressive symptoms in women with comorbid migraine: an open-label study.

Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:3

Topics: Adult; Depression; Female; Humans; Middle Aged; Migraine Disorders; Pyrrolidines; Quality of Life; Selective Serotonin Reuptake Inhibitors; Self Report; Serotonin Receptor Agonists; Sertraline; Tryptamines

2011

Other Studies

2 other study(ies) available for eletriptan and sertraline

Article	Year
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1 Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity	2013

Article

Year

Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.

Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010

Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.

Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1

Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity

2013